Atlas FDA

SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR

FDA premarket approval P110042/S035 · decided 2014-05-30

Approval details

PMA number
P110042
Supplement
S035
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR
Generic name
Implantable cardioverter defibrillator (non-CRT)
Applicant
Boston Scientific Corporation
Date received
2014-05-08
Decision date
2014-05-30
Days to decision
22 days
Decision code
OK30
Product code
LWS
Advisory committee
Cardiovascular
Expedited review
No
Location
St Paul, MN
Statement
CHANGES RELATED TO MANUFACTURING PROCESS OF THE BATTERY INCLUDING QUALIFYING A NEW WELD MACHINE, MODIFYING THE INSULATING TAPE USED IN SHIPPING, AND NEW FIXTURES.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27